Biomarqueurs des cancers colorectaux utiles en pratique clinique – FMC-HGE
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - Annals of Oncology
APMG Colon Molecular Pathways
New combination therapy offers bowel cancer patients extra treatment option
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
RESISTANCE TO ANTI-EGFR THERAPIES IN COLORECTAL CANCER – Sanguine Bio Researcher Blog
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
Clinical management of metastatic colorectal cancer in the era of precision medicine - Ciardiello - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Y‑box‑binding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
Colorectal adenocarcinoma‐derived EGFR mutants are oncogenic and sensitive to EGFR‐targeted monoclonal antibodies, cetuximab and panitumumab - Kim - 2020 - International Journal of Cancer - Wiley Online Library
Les biomarqueurs prédictifs dans le cancer colorectal
The Role of the Epidermal Growth Factor Receptor in the Mechanism and Treatment of Colorectal Cancer - Nirit Yarom - Discovery Medicine
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer | Aging
Biomarkers in Targeted Therapy for Colorectal Cancer
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells | Oncotarget
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
![PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2e5f89dec8a25afc1d61dc3d7197afa33839845d/3-Figure2-1.png "PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar")
PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. - Abstract - Europe PMC
IJMS | Free Full-Text | Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
